The researchers observed that treatment was associated with reduced adipocyte size and altered lipid accumulation compared to control groups
PMID 16687029
KEY FEATURES High-purity AOD-9604 research peptide 5mg lyophilised powder per vial HPLC-MS verified purity (99.08%) Manufactured in accredited laboratories Sterile, tamper-evident vial suitable for laboratory handling Fast, discreet Australia-wide shipping SPECIFICATIONS Product Name AOD-9604 5mg Peptide Grade Research Grade Quantity 5mg per vial Form Lyophilised powder Purity 99.08% (HPLC-MS tested) Appearance White/off-white lyophilised powder Storage Conditions Cool, dry environment
If you are new to this space, you may want to read our guide on what peptides are used for to establish a baseline understanding
In your case, it should take 4 injections to get it all in
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent